VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
80 hedge funds and large institutions have $132M invested in Viracta Therapeutics, Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 23 increasing their positions, 25 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
16% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 19
Holders
80
Holding in Top 10
–
Calls
$5.78M
Puts
$2.45M
Top Buyers
| 1 | +$6.51M | |
| 2 | +$4.52M | |
| 3 | +$1.32M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$1.32M |
| 5 |
FWM
Frontier Wealth Management
Kansas City,
Missouri
|
+$1.03M |
Top Sellers
| 1 | -$4.64M | |
| 2 | -$3.98M | |
| 3 | -$2.13M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$1.51M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.5M |